Suppr超能文献

足细胞损伤作为IgA肾病的潜在治疗靶点:病理学能为我们提供指导吗?

Podocyte injury as a potential therapeutic target in IgA nephropathy: should pathology guide us?

作者信息

Haas Mark

机构信息

Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.

出版信息

Kidney Int. 2024 Jun;105(6):1165-1167. doi: 10.1016/j.kint.2024.03.021.

Abstract

The Oxford histopathologic classification (MEST-C: scores for lesions indicating active glomerular inflammation, mesangial [M] and endocapillary [E] hypercellularity as well as cellular or fibrocellular crescents [C], and for segmental glomerulosclerosis [S] and interstitial fibrosis and/or tubular atrophy [T]) is useful in helping assess prognosis in patients with IgA nephropathy. Elements of this classification indicative of active glomerular inflammation, endocapillary hypercellularity and crescents, also have been found to be responsive to immunosuppressive therapy, potentially including newer agents specifically targeting mediators of such inflammation. In this issue of Kidney International, Bellur and coworkers identify histopathologic subtypes of segmental glomerulosclerosis in IgA nephropathy showing podocyte injury that also behave like active lesions, including showing improved outcomes with immunosuppression. This podocyte injury, identifiable only by kidney biopsy, may represent a potential therapeutic target in some patients with IgA nephropathy.

摘要

牛津组织病理学分类(MEST-C:用于评估提示活动性肾小球炎症、系膜[M]和毛细血管内[E]细胞增多以及细胞性或纤维细胞性新月体[C]的病变,以及节段性肾小球硬化[S]和间质纤维化及/或肾小管萎缩[T]的评分)有助于评估IgA肾病患者的预后。该分类中提示活动性肾小球炎症、毛细血管内细胞增多和新月体的因素,也已被发现对免疫抑制治疗有反应,可能包括专门针对此类炎症介质的新型药物。在本期《国际肾脏病杂志》中,贝鲁尔及其同事确定了IgA肾病中节段性肾小球硬化的组织病理学亚型,这些亚型显示足细胞损伤,其表现也类似于活动性病变,包括免疫抑制治疗后预后改善。这种仅通过肾活检才能识别的足细胞损伤,可能是一些IgA肾病患者的潜在治疗靶点。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验